ChromaDex to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023
May 02 2023 - 8:32AM
Business Wire
ChromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global
bioscience company dedicated to healthy aging, announced that it
will hold a conference call on Wednesday, May 10, 2023 at 4:30 p.m.
ET to discuss its financial results for the first quarter, which
ended March 31, 2023. The financial results will be reported in a
press release after the close of regular stock market trading hours
on the same day as the conference call.
Investor Conference Call:
ChromaDex management will host an investor conference call to
discuss first quarter 2023 results and provide a general business
update on Wednesday, May 10, at 4:30 p.m. ET.
Participants should call in at least 10 minutes prior to the
call. The dial-in information is as follows:
Date: Wednesday, May 10, 2023 Time: 4:30 p.m. ET (1:30 p.m. PT)
Toll-free dial-in number: 1-888-330-2446 Conference ID: 4126168
Webcast link: ChromaDex First Quarter 2023 Earnings Conference
Call
The conference call will be broadcast live and available for
replay here and via the investor relations section of the Company’s
website at www.chromadex.com.
A replay of the conference call will be available from 7:30 p.m.
ET on May 10, 2023, to 11:59 p.m. ET on May 17, 2023.
Toll-free replay number: 1-800-770-2030 Replay ID: 4126168
About ChromaDex:
ChromaDex Corp. is a global bioscience company dedicated to
healthy aging. The ChromaDex team, which includes world-renowned
scientists, is pioneering research on nicotinamide adenine
dinucleotide (NAD+), levels of which decline with age. ChromaDex is
the innovator behind NAD+ precursor nicotinamide riboside (NR),
commercialized as the flagship ingredient Niagen®. Nicotinamide
riboside and other NAD+ precursors are protected by ChromaDex’s
patent portfolio. ChromaDex maintains a website at
www.chromadex.com to which ChromaDex regularly posts copies of its
press releases as well as additional financial information about
the Company.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230502005490/en/
ChromaDex Media Contact: Kendall Knysch, Director of
Media Relations +1 (310) 388-6706 ext. 689
Kendall.Knysch@ChromaDex.com
ChromaDex Investor Relations Contact: +1 (949) 356-1620
InvestorRelations@ChromaDex.com
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Apr 2024 to May 2024
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From May 2023 to May 2024